Erlotinib versus pemetrexed for pretreated non-squamous non-small cell lung cancer patients in clinical practice.

Jon Zugazagoitia,Javier Puente,José Luis González Larriba,Aránzazu Manzano,Miguel Sotelo,Susana Hernandez,J. Sanz,P. Perez,E. Diaz-Rubio

Erlotinib versus pemetrexed for pretreated non-squamous non-small cell lung cancer patients in clinical practice.

2013

Jon Zugazagoitia
Javier Puente
José Luis González Larriba
Aránzazu Manzano
Miguel Sotelo
Susana Hernandez
J. Sanz
P. Perez
E. Diaz-Rubio

Background/Aim: Erlotinib and chemotherapy have shown similar efficacy for pretreated non-small cell lung cancer (NSCLC) patients, but none of the large studies h

Keywords:

Pemetrexed
Cell
Squamous non-small cell lung cancer
Clinical Practice
Second-line therapy
Erlotinib
Medicine
Lung cancer
Oncology
Chemotherapy
Internal medicine
non squamous
non small cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations